SNS-103
sensei biotherapeutics
['$snse', 'sensei']
$snse sensei biotherapeutics presents new preclinical data on sns-103 targeting entpdase1 (cd39) at the american association for cancer research (aacr) annual meeting 2023 #cancer #trading #stockmarket #investing
Stay ahead of the market with ultra-fast stock news updates. 
FREE with 15 sec delay. Upgrade to Gold for even faster news & exclusive features @ https://t.co/LViEqnfZ7i